Kalbe Farma Tbk vs Hetzer Medical Indonesia Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while Hetzer Medical Indonesia Tbk. trades at Rp82 (market cap 126.56B, 319.74M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 260.7× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (319.74M versus 98.44M). Which is the better fit depends on your goals.
| KLBF | MEDS | |
|---|---|---|
Market Cap | 33T | 126.56B |
Volume | 98.44M | 319.74M |
Lot | 984.38K | 3.2M |
Turnover | 70.64B | 27.4B |
Average Price | 717.58 | 85.68 |
Value | 70.64B | 27.4B |
Indicative Equilibrium Price | 720 | 82 |
Indicative Equilibrium Volume | 43.62K | 12.79K |
Trailing returns across standard periods
Latest headlines on both assets
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →